Loss of bile salt export pump aggravates lipopolysaccharide-induced liver injury in mice due to impaired hepatic endotoxin clearance.
ATP Binding Cassette Transporter, Subfamily B, Member 11
/ metabolism
Animals
Bile Acids and Salts
/ metabolism
Chemical and Drug Induced Liver Injury, Chronic
Cholestasis
/ pathology
Endotoxins
Inflammation
/ metabolism
Kinetics
Lipopolysaccharides
/ metabolism
Liver
/ pathology
Mice
Mice, Knockout
Journal
Hepatology (Baltimore, Md.)
ISSN: 1527-3350
Titre abrégé: Hepatology
Pays: United States
ID NLM: 8302946
Informations de publication
Date de publication:
05 2022
05 2022
Historique:
revised:
30
11
2021
received:
28
06
2021
accepted:
08
12
2021
pubmed:
21
12
2021
medline:
27
4
2022
entrez:
20
12
2021
Statut:
ppublish
Résumé
Lipopolysaccharide (LPS) clearance is delayed in cholestatic liver diseases. While compromised clearance by Kupffer cells (KCs) is involved, the role of LPS uptake into hepatocytes and canalicular excretion remains unclear. Wild-type (WT) and bile salt export pump (Bsep) knockout (KO) mice were challenged i.p. with LPS. Liver injury was assessed by serum biochemistry, histology, molecular inflammation markers, and immune cell infiltration. LPS concentrations were determined in liver tissue and bile. Subcellular kinetics of fluorescently labeled LPS was visualized by intravital two-photon microscopy, and the findings in Bsep KO mice were compared to common bile duct-ligated (BDL) and multidrug resistance protein 2 (Mdr2) KO mice. Changes in gut microbiota composition were evaluated by 16S ribosomal RNA gene amplicon sequencing analysis. Bsep KO mice developed more pronounced LPS-induced liver injury and inflammatory signaling, with subsequently enhanced production of proinflammatory cytokines and aggravated hepatic immune cell infiltration. After LPS administration, its concentrations were higher in liver but lower in bile of Bsep KO compared to WT mice. Intravital imaging of LPS showed a delayed clearance from sinusoidal blood with a basolateral uptake block into hepatocytes and reduced canalicular secretion. Moreover, LPS uptake into KCs was reduced. Similar findings with respect to hepatic LPS clearance were obtained in BDL and Mdr2 KO mice. Pretreatment with the microtubule inhibitor colchicine inhibited biliary excretion of LPS in WT mice, indicating that LPS clearance is microtubule-dependent. Microbiota analysis showed no change of the gut microbiome between WT and Bsep KO mice at baseline but major changes upon LPS challenge in WT mice. Absence of Bsep and cholestasis in general impair LPS clearance by a basolateral uptake block into hepatocytes and consequently less secretion into canaliculi. Impaired LPS removal aggravates hepatic inflammation in cholestasis.
Sections du résumé
BACKGROUND AND AIMS
Lipopolysaccharide (LPS) clearance is delayed in cholestatic liver diseases. While compromised clearance by Kupffer cells (KCs) is involved, the role of LPS uptake into hepatocytes and canalicular excretion remains unclear.
APPROACH AND RESULTS
Wild-type (WT) and bile salt export pump (Bsep) knockout (KO) mice were challenged i.p. with LPS. Liver injury was assessed by serum biochemistry, histology, molecular inflammation markers, and immune cell infiltration. LPS concentrations were determined in liver tissue and bile. Subcellular kinetics of fluorescently labeled LPS was visualized by intravital two-photon microscopy, and the findings in Bsep KO mice were compared to common bile duct-ligated (BDL) and multidrug resistance protein 2 (Mdr2) KO mice. Changes in gut microbiota composition were evaluated by 16S ribosomal RNA gene amplicon sequencing analysis. Bsep KO mice developed more pronounced LPS-induced liver injury and inflammatory signaling, with subsequently enhanced production of proinflammatory cytokines and aggravated hepatic immune cell infiltration. After LPS administration, its concentrations were higher in liver but lower in bile of Bsep KO compared to WT mice. Intravital imaging of LPS showed a delayed clearance from sinusoidal blood with a basolateral uptake block into hepatocytes and reduced canalicular secretion. Moreover, LPS uptake into KCs was reduced. Similar findings with respect to hepatic LPS clearance were obtained in BDL and Mdr2 KO mice. Pretreatment with the microtubule inhibitor colchicine inhibited biliary excretion of LPS in WT mice, indicating that LPS clearance is microtubule-dependent. Microbiota analysis showed no change of the gut microbiome between WT and Bsep KO mice at baseline but major changes upon LPS challenge in WT mice.
CONCLUSIONS
Absence of Bsep and cholestasis in general impair LPS clearance by a basolateral uptake block into hepatocytes and consequently less secretion into canaliculi. Impaired LPS removal aggravates hepatic inflammation in cholestasis.
Identifiants
pubmed: 34927748
doi: 10.1002/hep.32289
pmc: PMC9306629
pii: 01515467-202205000-00006
doi:
Substances chimiques
ATP Binding Cassette Transporter, Subfamily B, Member 11
0
Bile Acids and Salts
0
Endotoxins
0
Lipopolysaccharides
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1095-1109Informations de copyright
© 2022 The Authors. Hepatology published by Wiley Periodicals LLC on behalf of American Association for the Study of Liver Diseases.
Références
Stieger B, Meier Y, Meier PJ. The bile salt export pump. Pflugers Arch. 2007;453:611–20.
Stieger B. Role of the bile salt export pump, BSEP, in acquired forms of cholestasis. Drug Metab Rev. 2010;42:437–45.
Strautnieks SS, Byrne JA, Pawlikowska L, Cebecauerová D, Rayner A, Dutton L, et al. Severe bile salt export pump deficiency: 82 different ABCB11 mutations in 109 families. Gastroenterology. 2008;134:1203–14.
Wang R, Salem M, Yousef IM, Tuchweber B, Lam P, Childs SJ, et al. Targeted inactivation of sister of P‐glycoprotein gene (spgp) in mice results in nonprogressive but persistent intrahepatic cholestasis. Proc Natl Acad Sci U S A. 2001;98:2011–6.
Wang R, Sheps JA, Liu L, Han J, Chen PSK, Lamontagne J, et al. Hydrophilic bile acids prevent liver damage caused by lack of biliary phospholipid in Mdr2 –/– mice. J Lipid Res. 2019;60:85–97.
Hrycay E, Forrest D, Liu L, Wang R, Tai J, Deo A, et al. Hepatic bile acid metabolism and expression of cytochrome P450 and related enzymes are altered in Bsep –/– mice. Mol Cell Biochem. 2014;389:119–32.
Fuchs CD, Paumgartner G, Wahlström A, Schwabl P, Reiberger T, Leditznig N, et al. Metabolic preconditioning protects BSEP/ABCB11 –/– mice against cholestatic liver injury. J Hepatol. 2017;66:95–101.
Wang R, Chen HL, Liu L, Sheps JA, Phillips MJ, Ling V. Compensatory role of P‐glycoproteins in knockout mice lacking the bile salt export pump. Hepatology. 2009;50:948–56.
Trauner M, Meier PJ, Boyer JL. Molecular pathogenesis of cholestasis. N Engl J Med. 1998;339:1217–27.
Wagner M, Zollner G, Trauner M. New molecular insights into the mechanisms of cholestasis. J Hepatol. 2009;51:565–80.
Reynolds JV, Murchan P, Leonard N, Clarke P, Keane FB, Tanner WA. Gut barrier failure in experimental obstructive jaundice. J Surg Res. 1996;62:11–6.
Cabrera‐Rubio R, Patterson AM, Cotter PD, Beraza N. Cholestasis induced by bile duct ligation promotes changes in the intestinal microbiome in mice. Sci Rep. 2019;9:12324.
Dhillon AK, Kummen M, Trøseid M, Åkra S, Liaskou E, Moum B, et al. Circulating markers of gut barrier function associated with disease severity in primary sclerosing cholangitis. Liver Int. 2019;39:371–81.
Pavlidis ET, Pavlidis TE. Pathophysiological consequences of obstructive jaundice and perioperative management. Hepatobiliary Pancreat Dis Int. 2018;17:17–21.
Schwabe RF, Seki E, Brenner DA. Toll‐like receptor signaling in the liver. Gastroenterology. 2006;130:1886–900.
Van Bossuyt H, De Zanger RB, Wisse E. Cellular and subcellular distribution of injected lipopolysaccharide in rat liver and its inactivation by bile salts. J Hepatol. 1988;7:325–37.
Mimura Y, Sakisaka S, Harada M, Sata M, Tanikawa K. Role of hepatocytes in direct clearance of lipopolysaccharide in rats. Gastroenterology. 1995;109:1969–76.
Maitra SK, Rachmilewitz D, Eberle D, Kaplowitz N. The hepatocellular uptake and biliary excretion of endotoxin in the rat. Hepatology. 1981;1:401–7.
Clements WD, Halliday MI, McCaigue MD, Barclay RG, Rowlands BJ. Effects of extrahepatic obstructive jaundice on Kupffer cell clearance capacity. Arch Surg. 1993;128:200–4; discussion 204–5.
Pain JA. Reticulo‐endothelial function in obstructive jaundice. Br J Surg. 1987;74:1091–4.
Shibayama Y. Endotoxaemia and hepatic injury in obstructive jaundice. J Pathol. 1989;159:335–9.
Fuchs CD, Paumgartner G, Mlitz V, Kunczer V, Halilbasic E, Leditznig N, et al. Colesevelam attenuates cholestatic liver and bile duct injury in Mdr2 –/– mice by modulating composition, signalling and excretion of faecal bile acids. Gut. 2018;67:1683–91.
Ghallab A, Hofmann U, Sezgin S, Vartak N, Hassan R, Zaza A, et al. Bile microinfarcts in cholestasis are initiated by rupture of the apical hepatocyte membrane and cause shunting of bile to sinusoidal blood. Hepatology. 2019;69:666–83.
Fuchs CD, Krivanec S, Steinacher D, Mlitz V, Wahlström A, Stahlman M, et al. Absence of Bsep/Abcb11 attenuates MCD diet‐induced hepatic steatosis but aggravates inflammation in mice. Liver Int. 2020;40:1366–77.
Petruk G, Puthia M, Petrlova J, Samsudin F, Strömdahl A‐C, Cerps S, et al. SARS‐CoV‐2 spike protein binds to bacterial lipopolysaccharide and boosts proinflammatory activity. J Mol Cell Biol. 2021;12:916–32.
Reif R, Ghallab A, Beattie L, Günther G, Kuepfer L, Kaye PM, et al. In vivo imaging of systemic transport and elimination of xenobiotics and endogenous molecules in mice. Arch Toxicol. 2017;91:1335–52.
Geier A, Dietrich CG, Voigt S, Ananthanarayanan M, Lammert F, Schmitz A, et al. Cytokine‐dependent regulation of hepatic organic anion transporter gene transactivators in mouse liver. Am J Physiol Gastrointest Liver Physiol. 2005;289:G831–41.
Trauner M, Arrese M, Soroka CJ, Ananthanarayanan M, Koeppel TA, Schlosser SF, et al. The rat canalicular conjugate export pump (Mrp2) is down‐regulated in intrahepatic and obstructive cholestasis. Gastroenterology. 1997;113:255–64.
Bailey ME. Endotoxin, bile salts and renal function in obstructive jaundice. Br J Surg. 1976;63:774–8.
Deitch EA, Sittig K, Li M, Berg R, Specian RD. Obstructive jaundice promotes bacterial translocation from the gut. Am J Surg. 1990;159:79–84.
Assimakopoulos SF, Scopa CD, Vagianos CE. Pathophysiology of increased intestinal permeability in obstructive jaundice. World J Gastroenterol. 2007;13:6458–64.
Trauner M, Arrese M, Lee H, Boyer JL, Karpen SJ. Endotoxin downregulates rat hepatic ntcp gene expression via decreased activity of critical transcription factors. J Clin Invest. 1998;101:2092–100.
Trauner M, Fickert P, Stauber RE. Inflammation‐induced cholestasis. J Gastroenterol Hepatol. 1999;14:946–59.
Scott‐Conner CE, Grogan JB. The pathophysiology of biliary obstruction and its effect on phagocytic and immune function. J Surg Res. 1994;57:316–36.
Kennedy JA, Clements WDB, Kirk SJ, McCaigue MD, Campbell GR, Erwin PJ, et al. Characterization of the Kupffer cell response to exogenous endotoxin in a rodent model of obstructive jaundice. Br J Surg. 1999;86:628–33.
Nakano H, Fujiwara Y, Kitamura N, Kumada K, Matsumiya A, Sakai H, et al. Susceptibility to lipopolysaccharide of cholestatic rat liver produced with bile duct ligation: assessments of the mitochondrial glutathione pool and the effects of N‐acetylcysteine. Eur Surg Res. 2000;32:148–54.
Hori Y, Ohyanagi H. Biliary excretion of lipopolysaccharide is microtubule‐dependent in isolated perfused rat liver. J Gastroenterol. 1994;29:800–1.
Marks DL, LaRusso NF, McNiven MA. Isolation of the microtubule‐vesicle motor kinesin from rat liver: selective inhibition by cholestatic bile acids. Gastroenterology. 1995;108:824–33.
Lam P, Wang R, Ling V. Bile acid transport in sister of P‐glycoprotein (ABCB11) knockout mice. Biochemistry. 2005;44:12598–605.
Chou MH, Chuang JH, Eng HL, Tsai PC, Hsieh CS, Liu HC, et al. Effects of hepatocyte CD14 upregulation during cholestasis on endotoxin sensitivity. PLoS One. 2012;7:e34903.
Ju C, Tacke F. Hepatic macrophages in homeostasis and liver diseases: from pathogenesis to novel therapeutic strategies. Cell Mol Immunol. 2016;13:316–27.